Professor Norman Saunders, an expert on developmental neuroscience, has spoken out on the science behind the controversy over paracetamol use in pregnancy.
Deputy Vice-Chancellor (Research) Professor Jim McCluskey said the first tranche of funding would help ensure Australia remains at the forefront of medical research.
“We applaud the Federal Government’s commitment to medical research and innovation,” Professor McCluskey said.
“It is pleasing to see enhanced support of existing NHMRC schemes to support clinical researchers. This is an investment in the next generation of clinical research leaders and facilitates the translation of biomedical research to clinical practice.”
The first disbursements from the MRFF focus on translating research into health benefits, expansion of clinical trials capacity, and supplementary support for clinical researchers, collectively enhancing Australia’s reputation for research excellence and leadership.
Dean of the Faculty of Medicine, Dentistry and Health Sciences and Assistant Vice-Chancellor (Health) Professor Shitij Kapur also welcomed the announcement.
“This will give patients new opportunities to gain access to the very latest in care and treatment,” Professor Kapur said.
“It provides a pipeline for the next generation of clinical leaders, and will help translate their medical research into very real improvements in the health of Australians”
“This announcement highlights the importance of the MRFF to Australia, and our position at the forefront of cutting edge healthcare.”